Max Robotics — Global Service Robot Directory + US Certification

About

Anthony DeNovio is a health outcomes researcher whose work sits at the intersection of urologic oncology and cost-effectiveness analysis. His research focuses on two critical areas: the comparative economic value of minimally invasive treatments for renal masses, and the optimization of functional urinary outcomes following prostate cancer surgery. DeNovio’s most influential work, a 2022 cost-effectiveness analysis comparing percutaneous microwave ablation to robotic-assisted partial nephrectomy for small renal masses (11 citations), provides crucial evidence for value-based clinical decision-making. He has further refined this economic perspective with a perioperative cost comparison (6 citations), helping to clarify the financial trade-offs between these two approaches. In the prostate cancer space, DeNovio has made significant contributions to understanding post-surgical urinary function, publishing a series of studies (2023) that identify predictors of urgency and incontinence following robotic-assisted laparoscopic prostatectomy. Notably, he developed and evaluated a novel online comprehensive pelvic floor therapy program, comparing its effectiveness against both in-person specialist-directed therapy and unsupervised exercises. This work addresses critical access barriers to pelvic floor rehabilitation, offering scalable solutions for improving patients’ quality of life after prostatectomy.